Hostname: page-component-76d6cb85b7-jhrpq Total loading time: 0 Render date: 2026-07-14T15:11:13.233Z Has data issue: false hasContentIssue false
  • English
  • Français

Hermansky-Pudlak syndrome presenting with paranoid delusion

Published online by Cambridge University Press:  02 November 2022

Nishi Parikh ,
Aravind Menon Open the ORCID record for Aravind Menon [Opens in a new window] ,
Aimin Mitwally ,
Janeni Nayagan ,
Gretchen E. Magnani ,
Francis Aguilar  and
Maju M. Koola
Nishi Parikh
Affiliation:
Cooper Medical School of Rowan University, Camden, NJ, USA
Aravind Menon
Affiliation:
St. George’s University School of Medicine, True Blue, Grenada
Aimin Mitwally
Affiliation:
Department of Psychiatry and Behavioral Health, Cooper University Hospital Care, Camden, NJ, USA
Janeni Nayagan
Affiliation:
Department of Psychiatry and Behavioral Health, Cooper University Hospital Care, Camden, NJ, USA
Gretchen E. Magnani
Affiliation:
Department of Psychiatry and Behavioral Health, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ, USA
Francis Aguilar
Affiliation:
Department of Psychiatry and Behavioral Health, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ, USA
Maju M. Koola*
Affiliation:
Department of Psychiatry and Behavioral Health, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ, USA
*
*Author for correspondence: Maju M. Koola, MD, Emails: koola-maju@cooperhealth.edu; majumkoola@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Keywords

Paranoid DelusionHPS Type 3Hermanski-Pudlak SyndromeOculocutaneous AlbinismHPS Paranoid Delusion

Information

Type
Letter to the Editor
Information
CNS Spectrums , Volume 28 , Issue 5 , October 2023 , pp. 528 - 529
Copyright
© The Author(s), 2022. Published by Cambridge University Press

To the Editor,

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder with classical presentations of oculocutaneous albinism, a bleeding diathesis due to the absence of dense bodies in platelets, pulmonary fibrosis, and granulomatous colitis.Reference Alcid, Kim, Bruni and Lawrence1–Reference Seward and Gahl3 These systemic manifestations are due to lysosome-related organelle dysfunction.Reference Alcid, Kim, Bruni and Lawrence1 HPS can present as 1 of 9 subtypes, each due to specific mutation variations, with types 1 and 4 being the most severe.Reference Alcid, Kim, Bruni and Lawrence1 Mutations in the HPS1 gene are responsible for the majority of HPS cases.Reference Alcid, Kim, Bruni and Lawrence1 HPS type 3 classically presents milder than the other 8 subtypes.Reference Alcid, Kim, Bruni and Lawrence1 HPS type 4 has shown an increased susceptibility to schizophrenia.Reference Saito, Kuratomi and Ito4, Reference Kuratomi, Saito and Ozeki5

Case

A 19-year-old male with a past medical history of HPS type 3 (how he was diagnosed and age at diagnosis could not be determined from his chart), currently asymptomatic, and no past psychiatric history exhibited new-onset paranoid delusion over a 24-h period in April 2022. The patient expressed a belief that his family members were conspiring to kill him using a knife. The next day, he fled to his uncle’s house for safety, where the police were called, and the patient was brought to the emergency department (ED). In the ED, the patient endorsed previous suicidal ideation but denied homicidal ideation, auditory or visual hallucinations, and substance use. Initial laboratory tests were significant for a negative urine drug screen.

Due to new-onset paranoid delusions, the patient was voluntarily admitted to the inpatient psychiatric unit to provide respite from psychosocial stressors, medication management, and therapy. He revealed that he recently voluntarily withdrew from college, citing declining mental health, and now lives with his parents and 3 younger siblings, one of whom is also diagnosed with HPS type 3. There was no family history of psychosis. The patient was started on aripiprazole 5 mg and was gradually increased to 15 mg for psychosis. The patient’s hospital course was otherwise unremarkable with the resolution of his paranoia, and he tolerated the medication with no significant adverse reactions. He was discharged home and later admitted to a partial hospitalization program for 2 weeks, where he was switched to olanzapine 5 mg nightly. We do not know why this switch was made. He continues to follow up with outpatient psychiatry and plans to return to college during the next academic year.

Discussion

To the best of our knowledge, this is the first report of HPS type 3 presenting with psychiatric issues—he had paranoid delusion. HPS is a rare, multisystem disorder, and previous studies have shown an increased susceptibility to schizophrenia in patients with HPS type 4.Reference Saito, Kuratomi and Ito4 Our patient had HPS type 3 with no past psychiatric history, but he experienced paranoid delusions, suggesting that there may be a genetic predisposition to psychiatric illness in patients with the type 3 variant as well. Further studies should explore this association, as this knowledge may allow for improved awareness of this differential diagnosis (HPS types 3 and 4 with psychosis). When treating patients with HPS, it may be important to obtain a thorough psychiatric history and to make the patient aware of the association of HPS with psychosis.

Acknowledgments

N.P. and Ar.M. would like to thank Cooper University Hospital and M.M.K., the attending psychiatrist. A.M., J.N. (Residents), F.A., M.M.K., and G.E.M. (Attendings) were the treating psychiatrists. N.P. (Medical Student) also participated in patient care.

Financial Support

There was no funding for this manuscript preparation.

Author Contributions

N.P. and Ar.M. wrote the manuscript under the mentorship of Dr. Koola. All authors edited the manuscript with intellectual contributions. All authors approved the final version of the manuscript.

Disclosure

The authors report no financial relationships, conflict of interest, or otherwise related to the submitted work.

Footnotes

N.P. and Ar.M. contributed equally to this work.

References

Alcid, J, Kim, J, Bruni, D, Lawrence, I. A rare case of Hermansky-Pudlak syndrome type 3. J Hematol. 2018;7(2):76–78.CrossRefGoogle ScholarPubMed
De Jesus Rojas, W, Young, LR. Hermansky-Pudlak syndrome. Semin Respir Crit Care Med. 2020;41(2):238–246.Google ScholarPubMed
Seward, SL, Gahl, WA. Hermansky-Pudlak syndrome: health care throughout life. Pediatrics 2013;132(1):153–160.CrossRefGoogle ScholarPubMed
Saito, A, Kuratomi, G, Ito, C, et al. An association study of the Hermansky-Pudlak syndrome type 4 gene in schizophrenic patients. Psychiatr Genet. 2013;23(4):163–173.CrossRefGoogle ScholarPubMed
Kuratomi, G, Saito, A, Ozeki, Y, et al. Association of the Hermansky-Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects. BMC Psychiatry 2013;13:276.CrossRefGoogle ScholarPubMed